检索结果-南通市图书馆

Alendronate treatment does not inhibit bone formation within biphasic calcium phosphate ceramics in posterolateral spinal fusion： an experimental study in porcine model

引用

Chinese Medical Journal 2009年第22期122卷 2770-2774页

作者： XUE Qing-yun JI Quan LI Hai-sheng ZOU Xue-nong Niels Egund martin lind.finn b christensen Cody bringer Orthopedics Research Laboratory Spree Section E Institute Ior Experimental Clinical Research Aarhus University Hospital Aarhus Denmark Department of Orthopedic Beijing Hospital Beijing 100730 China ng Hospital Beijing 100730China

background biphasic calcium phosphate （bCP） ceramics has a potential advantage as an osteoconductive matrix and has an optimal resorption rate for bone formation. Using bCP ceramics as a bone graft during spinal fusion requires osteogenesis within the material and subsequent bridging between adjacent vertebraes to provide long-term support. bisphosphonates have been reported to prolong the process of bone healing. The influence of bisphosphonate treatment on bone formation within bCP ceramics in spinal fusion remains unknown. The aim of this study was to evaluate the influence of alendronate on bCP osteoaenesis in Dosterolateral spinal fusion.Methods Posterolateral spinal fusion with pedicle screw fixation was performed at the lumbar spine in twenty-two pigs. bCP ceramics were applied as a bone graft to obtain bone fusion between adjacent transverse processes. Eleven pigs in the treatment group received oral alendronate 10 mg/d for three months postoperatively. Eleven pigs in the control group did not receive treatment with alendronate. All animals underwent posterolateral spinal fusion with bCP ceramics. The fusion rate was evaluated three months after the operation.Results The fusion rates evaluated by X-ray were 27.3% in the treatment group and 20% in the control group. The fusion rates using histological evaluation were 18.2% in the treatment group and 20% in the control group. The mean volumes of fusion mass were （3.64±0.86） cm^3 in the treatment group and （4.26±0.63） cm^3 in the control group. No significant differences were found in either trabecular bone volume or residual bCP volume between treatment and control groups using histological evaluation. The new bone formation within bCP ceramics was greater in the area adjacent to transverse process （P 〈0.01）.Conclusion Oral alendronate with a dose of 10 mg daily do not inhibit bone formation within bCP ceramics or affect the fusion rate in posterolateral spinal fusion from porcine models.

关键词： spinal fusion alendronate calcium phosphate computed tomography

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：